| Literature DB >> 27496082 |
E Guillén-Gómez1,2, I Dasilva2,3, I Silva2,4, Y Arce2,5, C Facundo2,4, E Ars1,2, A Breda2,6, A Ortiz7, L Guirado2,4, J A Ballarín2,3, M M Díaz-Encarnación2,3.
Abstract
Kidney transplants from living donors (LDs) have a better outcome than those from deceased donors (DDs). Different factors have been suggested to justify the different outcome. In this study, we analyzed the infiltration and phenotype of monocytes/macrophages and the expression of inflammatory and fibrotic markers in renal biopsy specimens from 94 kidney recipients (60 DDs and 34 LDs) at baseline and 4 months after transplantation. We evaluated their association with medium- and long-term renal function. At baseline, inflammatory gene expression was higher in DDs than in LDs. These results were confirmed by the high number of CD68-positive cells in DD kidneys, which correlated negatively with long-term renal function. Expression of the fibrotic markers vimentin, fibronectin, and α-smooth muscle actin was more elevated in biopsy specimens from DDs at 4 months than in those from LDs. Gene expression of inflammatory and fibrotic markers at 4 months and difference between 4 months and baseline correlated negatively with medium- and long-term renal function in DDs. Multivariate analysis point to transforming growth factor-β1 as the best predictor of long-term renal function in DDs. We conclude that early macrophage infiltration, sustained inflammation, and transforming growth factor-β1 expression, at least for the first 4 months, contribute significantly to the difference in DD and LD transplant outcome. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.Entities:
Keywords: basic (laboratory) research/science; biopsy; donors and donation; fibrosis; graft survival; kidney (allograft) function/dysfunction; kidney transplantation/nephrology; molecular biology; translational research/science
Mesh:
Year: 2016 PMID: 27496082 DOI: 10.1111/ajt.13998
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 8.086